Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|9|1|31-39

ISSN： 1570-162X

Source： Current HIV Research, Vol.9, Iss.1, 2011-01, pp. : 31-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

By Uy Jonathan   Yang Rong   Wirtz Victoria   Sheppard Louise   Farajallah Awny   McGrath Donnie  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1500-1504

Routledge Ltd

Access to resources Recommend Favorite

The POWER and TITAN trials: darunavir/ritonavir in the management of HIV-infected patients

By Katlama Christine  

Future HIV Therapy, Vol. 2, Iss. 3, 2008-05 ,pp. : 229-245

Future Medicine

Access to resources Recommend Favorite

Ultrasonography and Anthropometry for Measuring Regional Body Fat in HIV-Infected Patients

By  

Current HIV Research, Vol. 5, Iss. 5, 2007-09 ,pp. : 459-466

Bentham Science Publishers

Access to resources Recommend Favorite

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy

By Lê Minh P.   Stitou Hind   Soulie Cathia   Katlama Christine   Peytavin Gilles  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 727-729

Oxford University Press

Access to resources Recommend Favorite

Neurosyphilis in HIV-infected patients

By Philip Susan S   Klausner Jeffrey D  

Future HIV Therapy, Vol. 2, Iss. 6, 2008-11 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite